3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
17
Myelodysplastic Syndromes
9
Leukemia, Myelomonocytic, Chronic
4
Myeloproliferative Disorders
3
Myelodysplastic-Myeloproliferative Diseases
2
Leukemia, Biphenotypic, Acute
2
Triple Negative Breast Neoplasms
1
Thrombocythemia, Essential
1
Systemic Mastocytosis With an Associated Hematologic Neoplasm
1
Primary Myelofibrosis
1
Polycythemia Vera
1
Mesothelioma, Malignant
1
Mesothelioma
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, B-Cell
1
Hodgkin Disease
1
GATA2 Deficiency
1
Cytopenia
1
Central Nervous System Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Merkel Cell
1
BRCA1 Mutation
1
Anemia, Refractory, with Excess of Blasts
1
Allogeneic Stem Cell Transplantation
1
Interventions
Nivolumab
3
selinexor
2
pembrolizumab
2
pazopanib
2
Radiotherapy
2
Radiation
2
Magnetic Resonance Spectroscopy
2
Ifosfamide
2
Doxorubicin
2
tazemetostat
1
metarrestin
1
fludarabine phosphate
1
fludarabine
1
Specimen Handling
1
Sirolimus
1
Proton Therapy
1
Mesna
1
Ipilimumab
1
Cyclophosphamide
1
CTLA-4 Antigen
1
BO-112
1
AZD 6244
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neurofibrosarcoma
×
decitabine and cedazuridine drug combination
×
90 days
×
Clear all
No trials found.